Health
Moderna increases minority numbers in its vaccine trial, but still not meeting Fauci’s goal – CNN
Moderna, which is making a vaccine against Covid-19, has enrolled more minorities in its trial.
(CNN)Moderna, the first US company to begin Phase 3 clinical trials of a coronavirus vaccine in the US, increased its enrollment of minorities this week, but is still not even close to the levels requested by Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
So far, 24% of study participants “are from communities of color,” according to postings on the company’s website and Twitter account. Last week, the company said 18% of the participants were minorit…
-
Business12 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General22 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News12 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business15 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025